Drug-induced immunological neutropenia

Area of Science:

• Immunology
• Hematology
• Pharmacology

Background:

• Neutropenia, a condition characterized by low neutrophil counts, can be idiopathic or drug-induced.
• Drug-induced neutropenia is a significant clinical concern, often mediated by immune mechanisms.

Purpose of the Study:

• To investigate the presence and characteristics of antineutrophil antibodies in patients with drug-induced neutropenia.
• To explore the relationship between specific drugs and the development of these antibodies.

Main Methods:

• Sera from neutropenic patients were tested for antineutrophil antibody activity.
• Antibody activity was assessed for complement dependence and drug concentration effects.
• Immunoglobulin class (IgM, IgG) was investigated in specific cases.

Main Results:

• Antineutrophil antibodies capable of opsonizing neutrophils were detected in 16 neutropenic patients.
• Antibody activity decreased or disappeared upon cessation of drug therapy.
• Opsonization linked to semisynthetic penicillins was drug-dependent and complement-independent.
• Complement-dependent activity was observed in patients on methimazole and multiple medications, with IgM involvement in one case.
• Complement-independent IgG antibody was found in another patient on multiple drugs.

Conclusions:

• Certain drugs, including semisynthetic penicillins, antimicrobials, and antithyroid agents, can induce neutropenia via antineutrophil antibodies.
• The cessation of causative drug therapy is an effective strategy for managing drug-induced neutropenia.
• The mechanisms of antibody-mediated neutropenia can involve complement-dependent or independent pathways and different immunoglobulin classes.